predicting response to parp inhibitor therapy in ovarian cancer
Published 6 years ago • 102 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
0:55
overcoming resistance to parp inhibitors in ovarian cancer
-
2:34
ovarian cancer: molecular testing and parp inhibitors
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
6:52
case 3: benefit of parp inhibitor maintenance in ovarian cancer
-
1:59
ovarian cancer subtypes may predict response to bevacizumab
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
53:15
will new antibody drug conjugates cure bladder cancer?
-
1:38
updates in parp inhibition for ovarian cancer
-
1:26
dr. penson on biomarkers of response to parp inhibitors in ovarian cancer
-
5:06
ovarian cancer: the role of parp inhibitors and beyond
-
2:21
olaparib: predicting response in breast cancer
-
24:56
gynecologic cancer education: parp inhibitor therapy
-
0:46
parp inhibitor rechallenging in ovarian cancer
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
3:05
an overview of parp inhibitors in ovarian cancer
-
1:52
dr. konecny on response to parp inhibitors in ovarian cancer
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer